Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?
- PMID: 38733083
- DOI: 10.1080/14737140.2024.2354772
Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?
Keywords: PD-L1; Recurrent/metastatic head and neck cancer; cetuximab; chemotherapy; combined positive score; pembrolizumab.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials